Docetaxel 80 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FJ3KJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,094
Award facts
- Contract value 100% obligated
- $1,093.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Docetaxel 80 mg/4 mL vials valued at $1,093.69. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside competitive award. The products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's comprehensive SPE2DX IDC vehicle serves as a global pharmaceutical support mechanism enabling the supply of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. Docetaxel, a chemotherapy agent, is among the specialized pharmaceutical products the company delivers through its federal contract portfolio, which encompasses both brand-name and generic medications across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FJ3KJ?
SPE2DB25FJ3KJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FJ3KJ worth?
The government has obligated $1,094 on SPE2DB25FJ3KJ.
Is contract SPE2DB25FJ3KJ an order under another contract?
Yes. SPE2DB25FJ3KJ is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ3KJ competed?
The extent of competition for SPE2DB25FJ3KJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award